Search for Clinical Trial Results

Sponsored By

Medulloblastoma, Childhood - 13 Studies Found

Status Study
Completed Study Name: Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Condition:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Suprate
    Date: 2006-06-08
    Interventions:
    • Drug: etoposide Given IV
Completed Study Name: Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor
Condition:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Suprate
    Date: 2000-11-06
    Interventions:
    • Drug: cisplatin Given IV
Active, not recruiting Study Name: Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
Condition:
  • Recurrent Childhood Medulloblastoma
  • Recurrent Childhood Pineobl
    Date: 2010-10-07
    Interventions:
    • Biological: Bevacizumab Given

Active, not recruiting Study Name: Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Condition:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Pineobl
    Date: 2009-03-20
    Interventions:
    • Radiation: 3-Dimensional Conformal Radiation Therapy

Recruiting Study Name: Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Condition:
  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Pineobl
    Date: 2006-10-25
    Interventions:
    • Radiation: Radiation Therapy U
Suspended Study Name: Gallium Ga 68-Edotreotide PET/CT Compared With Indium In 111 Pentetreotide Plus Contrast-Enhanced CT (or MRI) in Diagnosing Patients With Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
Condition:
  • Adult Medulloblastoma
  • Childhood Medulloblastoma
  • Date: 2013-05-31
    Interventions:
    • Radiation: gallium Ga 68-edotreotide

Recruiting Study Name: WEE1 Inhibitor MK-1775 and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Condition:
  • Childhood Central Nervous System Neoplasm
  • Recurrent Childhood Medullob
    Date: 2014-03-13
    Interventions:
    • Drug: Irinotecan Hydrochloride

Recruiting Study Name: Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery
Condition: Brain and Central Nervous System Tumors
Date: 2006-01-12
Interventions:
  • Drug: cisplatin
  • Drug: lomustine
Completed Study Name: Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
Condition:
  • Brain Tumors
  • Central Nervous System Tumors

Date: 1999-11-01
Interventions:
  • Biological: filgrastim Other N
Completed Study Name: Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
Condition:
  • Brain Tumors
  • Central Nervous System Tumors

Date: 1999-11-01
Interventions:
  • Biological: filgrastim Other N
Next >>>